These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1137 related articles for article (PubMed ID: 17241888)

  • 1. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
    Gershon MD; Tack J
    Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and its role in colonic function and in gastrointestinal disorders.
    Costedio MM; Hyman N; Mawe GM
    Dis Colon Rectum; 2007 Mar; 50(3):376-88. PubMed ID: 17195902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
    Spiller R
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
    Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
    Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
    Tonini M; Pace F
    Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and GI clinical disorders.
    Spiller R
    Neuropharmacology; 2008 Nov; 55(6):1072-80. PubMed ID: 18687345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
    Sikander A; Rana SV; Prasad KK
    Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.
    Gershon MD
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():15-30. PubMed ID: 10429737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine and the gastrointestinal tract: where next?
    Sanger GJ
    Trends Pharmacol Sci; 2008 Sep; 29(9):465-71. PubMed ID: 19086255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of novel tryptophan hydroxylase inhibitors that selectively inhibit serotonin synthesis in the gastrointestinal tract.
    Liu Q; Yang Q; Sun W; Vogel P; Heydorn W; Yu XQ; Hu Z; Yu W; Jonas B; Pineda R; Calderon-Gay V; Germann M; O'Neill E; Brommage R; Cullinan E; Platt K; Wilson A; Powell D; Sands A; Zambrowicz B; Shi ZC
    J Pharmacol Exp Ther; 2008 Apr; 325(1):47-55. PubMed ID: 18192499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders].
    Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M
    Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serotonin in the pathophysiology of irritable bowel syndrome.
    Crowell MD
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S252-60. PubMed ID: 11474910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic therapy for the irritable bowel syndrome.
    Talley NJ
    Am J Gastroenterol; 2003 Apr; 98(4):750-8. PubMed ID: 12738451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets.
    Mawe GM; Hoffman JM
    Nat Rev Gastroenterol Hepatol; 2013 Aug; 10(8):473-86. PubMed ID: 23797870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of drugs for gastrointestinal motor disorders: translating science to clinical need.
    Sanger GJ; Alpers DH
    Neurogastroenterol Motil; 2008 Mar; 20(3):177-84. PubMed ID: 18257767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions.
    Grundy D
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():63-7. PubMed ID: 18924445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tegaserod for constipation-predominant irritable bowel syndrome.
    Kale-Pradhan PB; Wilhelm SM
    Pharmacotherapy; 2007 Feb; 27(2):267-77. PubMed ID: 17253916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.